Novel amide derivative for inhibiting the growth of cancer cells

Details for Australian Patent Application No. 2008260772 (hide)

International Classifications

Event Publications

28 January 2010 PCT application entered the National Phase

PCT publication WO2008/150118 Priority application(s): WO2008/150118

27 January 2011 Assignment before Grant

Hanmi Pharm. Co., Ltd. The application has been assigned to Hanmi Holdings Co., Ltd.

2 June 2011 Application Accepted

Published as AU-B-2008260772

29 September 2011 Standard Patent Sealed

6 September 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Hanmi Science Co., Ltd. . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.